May 01, 2015
Join our Circle of Friends
Receive updates about our research and events
Dr. Schmidt has a longstanding interest in the development of novel drug discovery-related technologies with a strong focus on entrepreneurship. His scientific expertise includes molecular and cell biology as well as assay development, high-throughput screening and high-content analysis. He is an inventor on nine Australian and international patents and the author of 16 original research publications. Prior to joining Genea (formerly Sydney IVF) in 2007, he was the co-founder of Dimerix Bioscience, a company based on novel GPCR drug screening technologies and the scientific founder of a European diagnostics/drug delivery company. Dr Schmidt is now an executive of Genea Limited and as General Manager of Genea Biocells shapes the company’s scientific direction and advances its business development.